Topics

Jacobs School of Medicine and Biomedical Sciences medical students celebrated their multicultural backgrounds at the annual Taste of Culture event Dec. 2 at the Jacobs School building.

Getting a paper published in the New England Journal of Medicine (NEJM) is a career-crowning achievement for any medical researcher. This fall, within one week, it happened to two members of the Department of Pediatrics in the Jacobs School of Medicine and Biomedical Sciences, both of whom also happen to be Jacobs School alumnae.

Nineteen faculty members with clinical and research experience have joined the departments of Medicine, Obstetrics and Gynecology, Orthopaedics, Pathology and Anatomical Sciences, Pediatrics, and Physiology and Biophysics.

Yongho Bae, PhD, assistant professor of pathology and anatomical sciences, has received a $250,000 sponsored research award from the Empire Discovery Institute (EDI) to investigate the role a novel mechanotherapeutic target, discovered in his lab, may have on vascular and cardiac stiffening commonly associated with cardiovascular disease (CVD). 

As the holiday season kicks into high gear, Jacobs School of Medicine and Biomedical Sciences physicians and scientists have recommendations for how people can stay safe and healthy this holiday season amid some increasingly concerning signs.

Gil I. Wolfe, MD, UB Distinguished Professor and the Irvin and Rosemary Smith Chair of the Department of Neurology, is involved in trials of FcRn (neonatal FC receptor) antagonists that offers a new approach to treating myasthenia gravis (MG).

A promising alternative to opioids being developed in the Buffalo and Rochester regions is one step closer to meeting a critical need in pain management, thanks to a pivotal business partnership and exclusive licensing agreements with the University at Buffalo.

Steven J. Fliesler, PhD, has been named the 2022 recipient of the Retina Research Foundation’s (RRF) Paul Kayser International Award in Retina Research presented by the International Society for Eye Research (ISER).

For teens who have struggled with obesity, it probably sounded too good to be true: a weekly injection that could help them control their eating and lead to weight loss. But the results of the clinical trial on the drug semaglutide, released earlier this month in the New England Journal of Medicine and presented at the discipline’s major conference, Obesity Week, turned out to be better than anything the participants — or even the researchers — expected.

The request by children’s hospitals nationwide this month that the federal government declare a formal state of emergency given the surge in respiratory syncytial virus (RSV) and flu cases was no surprise to Oscar G. Gómez, MD, PhD, associate professor of pediatrics.

Three members of the Jacobs School of Medicine and Biomedical Sciences faculty have been honored with SUNY Diversity in Medicine Mentoring Awards.

Thaddeus P. Waters, MD, has been installed as the inaugural Amol S. Lele, MD, Professor and Chief of the Division of Maternal-Fetal Medicine in the Department of Obstetrics and Gynecology at the Jacobs School of Medicine and Biomedical Sciences.

Kathleen E. Bethin, MD, PhD, clinical professor of pediatrics and her research team have been lauded by the Pediatric Diabetes Consortium (PDC) for their contributions to the PIONEER TEENS clinical trial sponsored by the Danish pharmaceutical company Novo Nordisk.

Viewing intentional violence as a public health issue has led Robert Gore, MD ’02, down an interesting path, both personally and professionally.

The Jacobs School of Medicine and Biomedical Sciences researchers who have changed the way concussions are treated have been awarded $4.8 million from the U.S. Department of Defense (DOD) to conduct a clinical trial to evaluate whether incorporating elements from the Buffalo Concussion Protocol to the DOD’s current concussion protocol would improve outcomes for active members of the military who sustain a concussion.

A Jacobs School of Medicine and Biomedical Sciences researcher has been awarded a National Heart, Lung and Blood Institute grant to explore how changes in arterial stiffness elicit vascular smooth muscle cell (VSMC) behaviors that contribute to cardiovascular disease.

A team of Jacobs School of Medicine and Biomedical Sciences researchers has published a paper that provides novel guidelines for clinicians when discussing brain atrophy with their multiple sclerosis (MS) patients.

The late Jonathan D. Daniels, MD ’98, had a clear mission in life — to erase the term “underrepresented minorities in medicine” from the health care lexicon.

The legacy of the late Jonathan D. Daniels, MD ’98, lives on through the many students he mentored while encouraging them to apply to medical school and those he guided through its rigorous environment once they arrived.

A Black Men in White Coats chapter has been established at the Jacobs School of Medicine and Biomedical Sciences and is named in honor of the late Jonathan D. Daniels, MD ’98, the school’s former associate director of admissions who died July 4 in a fire at his North Buffalo home.